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In the 14 July 1997, issue ofLancet,Schlemper et al.
[1] reported a study in which four Japanese and four
Western pathologists (from the United States, Canada,
Germany, and Finland) compared their diagnoses of gas-
tric biopsy and resection specimens having epithelial le-
sions ranging from reactive, through preneoplastic, to
invasive carcinoma. These pathologists independently
classified microscopic slides from 17 biopsies and 18
mucosal resections of 19 cases of neoplastic and nonneo-
plastic gastric epithelium. All of the lesions were super-
ficial, involving only the mucosa, or when invasive, not
extending beyond the submucosa, thus including ex-
amples of early gastric cancer. The selection of primarily
superficial lesions focused attention on the minimal cri-
teria required for the diagnosis of malignancy by pa-
thologists from different parts of the world. The pattern
that emerged indicated that the terminology favored by
the Japanese pathologists differed from that favored by
three of the Western pathologists for the same lesions;
the fourth Western pathologist sided with the Japanese.
Specifically, the Japanese pathologists’ threshold for di-
agnosing carcinoma was lower than that of the Western
pathologists. The Japanese did not require the presence
of invasion for a diagnosis of adenocarcinoma of the
stomach, whereas the Westerners did.
The authors suggest that the different diagnostic ap-
proaches brought out in this study reflect underlying dif-
ferences between Japanese and Western pathologists, as-
suming that the participating pathologists were represen-
tative of Western and Japanese pathologists in general.
Clearly, the Western group was not homogeneous, since
one member broke ranks and sided with the Japanese.
Therefore, we are asked to take it on faith that the opin-
ions and use of terminology of the other three Western
pathologists reflect the views of all Western pathologists,
whereas the four Japanese pathologists speak for all pa-
thologists in their country. This assumption is tenuous at
best; however, for the sake of this discussion, we accept it.
Eleven of the 12 cases diagnosed by the Japanese pa-
thologists as definite carcinoma on biopsy were also di-
agnosed as carcinoma on the subsequent mucosal resec-
tion by the same pathologists; the twelfth case was di-
agnosed as suspected carcinoma on the resection. In
contrast, for the same 12 cases, the Western pathologists
diagnosed definite carcinoma in only two biopsies, high-
grade dysplasia with suspected carcinoma in four biop-
sies, high-grade dysplasia alone in three biopsies, and
low-grade dysplasia in three biopsies. Definite carcinoma
was diagnosed in only three of the subsequent resections,
all of which were designated as either suspected or defi-
nite carcinoma on biopsy. Thus the Japanese and West-
ern pathologists were consistent in the application of
their own criteria to both biopsies and resection speci-
mens, and the differences in diagnoses are truly the result
of differences in diagnostic criteria and are not related to
sample size.
Two other cases diagnosed as low-grade dysplasia on
biopsy and resection by the Westerners were both diag-
nosed as definite carcinoma on biopsy and definite car-
cinoma and suspected carcinoma on resection by the
Japanese, again indicating consistency among members
of the two groups. However, in two additional cases that
were called low-grade dysplasia by the Western patholo-
gists, high-grade dysplasia and definite carcinoma were
diagnosed by these same pathologists in the resection
specimens, suggesting that Western low-grade dysplasia
may be more ominous than previously suspected. The
Japanese called these same two lesions definite carci-
noma and adenoma with severe atypia on biopsy and
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definite carcinoma in both on resection. In fact, of the
five cases that the Westerners called low-grade dysplasia,
the Japanese diagnosed definite carcinoma in three and
adenoma with severe atypia in a fourth, again indicating
a much more aggressive use of the term ‘‘carcinoma’’ by
the Japanese.
At first glance, the difference in diagnostic thresholds
between these two groups would seem to be intolerable.
In this age of international cooperation and data ex-
change, how can we in the medical community allow
things to be done so differently? What are the implica-
tions of such differences in the understanding and treat-
ment of early gastric cancer?
The results of this provocative study are appropriately
viewed from two perspectives. The first is the perspec-
tive of the physician/scientist interested in the implica-
tion of these differences to the collection, evaluation, and
comparison of data about gastric cancer from sites
throughout the world. The other is that of the physician
interested in accurately diagnosing and effectively man-
aging patients at risk for, or already having, gastric car-
cinoma.
There is a perception in the West that early gastric
cancers reported from Japan are invasive. For example,
in a recent review of early gastric cancer in Europe the
authors state that early gastric cancer can be divided into
those that invade the mucosa only and those that invade
the submucosa, but there is no mention of those that do
not invade [2]. Clearly, these authors assumed that early
gastric cancer was an invasive cancer, whether in the
West or in Japan.
However, it is apparent from the Schlemper et al. study
[1] that there are different criteria for the diagnosis of
gastric carcinoma in Japan as compared with some West-
ern countries. Recognition of this is critical if one at-
tempts to compare epidemiologic, diagnostic, and thera-
peutic data from Japanese studies with those performed
elsewhere. Western clinicians and pathologists to whom
these data are important are now compelled to re-
evaluate all published Japanese statistics on early gastric
cancer with an eye to discriminating those that include
cases in which invasion was present from those that do
not. Likewise, Japanese physicians must take care in in-
terpreting Western data. As only lesions that are invasive
are capable of metastasis, it is invalid to compare studies
that include noninvasive lesions with studies that include
only invasive lesions.
As an example, in a recent report from Japan, 48 le-
sions labeled as ‘‘early gastric cancer’’ were treated by
endoscopic resection [3]. Forty-five of these lesions were
confined to the mucosa, and only three invaded the sub-
mucosa. No mention was made in the report as to how
many of the 45 mucosal lesions invaded the lamina pro-
pria. Based upon the Schlemper et al. study [1], we sus-
pect that a number of these were noninvasive lesions,
possibly a substantial number, and perhaps that ac-
counted for the fabulous follow-up results in this report.
This article was published in a British journal. When it
was submitted for peer review, did the editors and re-
viewers realize that a number of these Japanese early
gastric cancers might be diagnosed as dysplasias by Brit-
i h pathologists, some of whom are on the editorial board
of this journal? We do not mean to imply that the treat-
ment was inappropriate. Endoscopic mucosal resection
may be a perfectly acceptable therapy for gastric epithe-
lial dysplasia as well as for some types of early gastric
cancer.
In an editorial comment accompanying the Schlemper
et al. [1] study, written by two members of a Japanese
surgery department, the authors did not feel that this
study indicated a need for Western clinicians to alter how
they interpret Japanese gastric cancer statistics [4]. Their
rationale for this position is not clear. In general, the
survival rates for gastric carcinoma have been superior in
Japan compared to the West for comparable depths of
invasion and stage. The superior Japanese survival sta-
tistics for early gastric cancer are precisely what are
called into question by this study. If invasion has not
b en a criterion for the diagnosis of adenocarcinoma in
other Japanese studies of early gastric cancer, one cannot
c mpare outcomes with groups of patients for whom
invasion was a requisite for a malignant diagnosis. Are
the better survival rates for early gastric cancer in Japan
genuine, or a manifestation of the inclusion of in situ
lesions that others, particularly those in the West, would
have excluded? Perhaps if noninvasive lesions are re-
moved from the Japanese data base for early gastric can-
cer, the survival rates in the West might match or even
surpass those in Japan.
Might these differences be minimized by insistence on
standardized terminology? The World Health Organiza-
tion (WHO) has published definitions for neoplasia in
ost body sites. In the latest version of the WHO clas-
sification of tumors of the esophagus and stomach, ad-
enocarcinoma of the stomach is defined as ‘‘a malignant
tumour of glandular epithelium composed of tubular, aci-
nar, or papillary structures’’ [5]. There is no mention of
vasion in this definition.
The WHO has another definition critical to this dis-
cussion, that of dysplasia, namely, ‘‘atypical changes in
the epithelium considered to be precancerous.’’ The three
Western pathologists limited their designation of adeno-
carcinoma to neoplastic epithelium with invasion at least
into the lamina propria, applying the term ‘‘dysplasia’’ to
neoplastic epithelium that did not invade. In contrast, for
the Japanese group, invasion was not a necessary crite-
rion for the diagnosis of carcinoma, and lesions were
diagnosed as carcinoma entirely in situ. In fact, they did
not use the term ‘‘dysplasia’’ for any lesion, but did
accept the term ‘‘adenoma.’’ The WHO defines adenoma
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as ‘‘a circumscribed benign neoplasm composed of tu-
bular and/or villous structures lined by dysplastic epithe-
lium.’’ Since the definition of adenoma includes the
word ‘‘dysplastic,’’ one can assume that, in fact, the
Japanese did, indeed, diagnose those lesions they called
adenomas as dysplasias. Therefore, both sets of patholo-
gists in the study, Japanese and Western, used terminol-
ogy set forth in the WHO definitions. The apparent dif-
ference between the two groups is not due to use of
different terminology, but a more basic difference of
opinion on what is already malignant and what is pre-
cancerous. Both the Japanese and Western pathologists
may adhere to the WHO definition of the word ‘‘adeno-
carcinoma,’’ but they seem to be at odds as to what the
word ‘‘malignant’’ means.
Do we need standardized nomenclature for the diag-
nosis of gastric mucosal neoplasia above and beyond that
offered by the WHO? Standardization of nomenclature
would have utility in communicating and understanding
data collected in different settings. If we decide that such
criteria are essential, they would have to include more
specific morphologic descriptors. In the case of early
gastric carcinoma, an international agreement as to the
importance of invasion is requisite.
It would seem, then, that insistence on the use of stan-
dard nomenclature for histologic lesions is not enough to
produce uniformity among reports. Authors of studies on
early gastric cancer, as on studies of virtually any pro-
cess, must state in their publications the criteria upon
which their diagnoses are made. In particular, they must
tell the readers whether invasion is or is not a criterion for
the diagnosis of carcinoma. Only in this way will it be
possible to compare Japanese and Western survival sta-
tistics for early gastric cancer.
Is the difference in diagnostic approach between pa-
thologists in different geographic regions of concern to
pathologists in any specific location in this world who
are striving accurately to diagnose gastric cancerous and
precancerous lesions? Perhaps the approaches preferred
by the pathologists who participated in this study reflect
the use of criteria appropriate to the different environ-
ments in which they live and work. The Japanese find
themselves in an environment with a high incidence of
gastric carcinoma, which means there is concern that the
threshold established for the diagnosis of carcinoma be
set at a level where a significant percentage of subse-
quent resections will harbor definite carcinoma, but not
so high as to miss the opportunity to cure patients. They
apparently have determined that threshold and are using
it. This threshold may be inappropriate for those practic-
ing in, for example, North America, where the incidence
of gastric carcinoma is much lower, and (presumably) the
predictive value of a noninvasive lesion for definite car-
cinoma would be lower.
The Japanese also find themselves in an environment
in which endoscopic mucosal resection is readily avail-
able to patients, so that the diagnosis of early gastric
carcinoma usually leads to such a relatively conservative
procedure. A Western pathologist who diagnoses gastric
carcinoma in a gastric biopsy is likely to have a gastrec-
tomy specimen follow. This pathologist is not going to be
wi ling to diagnose cancer without being certain of in-
vasion.
Is it justified to alter diagnostic terminology in order to
direct appropriate therapy? Certainly, we have already
chosen to tailor our diagnostic terminology to direct
therapy in some sites. For example, we in the West have
agreed not to diagnose carcinoma in the colon unless
there is submucosal invasion, because resection is not
indicated with lesions confined to the mucosa. Is it rea-
sonable for the Japanese to do the same? The answer
depends on the therapeutic implications for the diagnosis
of ‘‘colonic carcinoma’’ in Japan. Colectomy for an in-
tramucosal colonic neoplasm is dreadfully drastic
t erapy.
Would adherence to standardized nomenclature in dif-
ferent parts of the world improve patient care? At the
moment, there are no data covering this issue, but we
expect that the answer would be ‘‘probably not.’’ It
seems that Japanese and Western pathologists have suc-
cessfully evolved nomenclatures that serve the needs of
the patients on whose behalf the diagnosis are made.
In summary, the results of the Schlemper et al. study
[1] are of concern from the standpoint of interpreting
published data about early gastric cancer from patholo-
gists in different countries, as it exposed some profound
differences in diagnostic criteria. The fact that these dif-
ferences were not previously recognized should alert us
to examine other areas of diagnosis. Are our assumptions
bout the uniformity of diagnostic criteria throughout the
world correct for all diseases? It is important, then, that
the authors of any published report state clearly the cri-
teria upon which their cases are chosen. However, since
all peoples of the world are not the same and since the
diagnosis and treatment of early gastric cancer must
serve the patients, the methods of diagnosis and therapy
that have evolved must be recognized as well adapted to
their specific medical environments.
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